Innovative Medicines Canada calling on feds to clarify impact of pharmacare on private drug plans
Innovative Medicines Canada is calling on the federal government to introduce amendments to Bill C-64 that clarify the impact on all aspects of Canadians’ drug coverage. In a press release, the association urged the feds to ensure its new pharmacare program doesn’t disrupt existing coverage for the 27 million Canadians who are insured under a […]
- November 6, 2024 November 5, 2024
- 09:00